{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:13:50Z","timestamp":1790439230658,"version":"4.1.0"},"reference-count":18,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2007,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            MICs were determined for 15 antimicrobial agents against 37\n            <jats:italic>Mycoplasma putrefaciens<\/jats:italic>\n            isolates. The most effective antimicrobial drug classes were the fluoroquinolones, the tetracyclines, the lincosamide lincomycin, and the macrolides. The susceptibility profile of the isolates correlated with the geographic origin. This is the first report of decreased susceptibility to the macrolides, lincomycin, and the tetracyclines in\n            <jats:italic>M. putrefaciens<\/jats:italic>\n            strains.\n          <\/jats:p>","DOI":"10.1128\/aac.00420-07","type":"journal-article","created":{"date-parts":[[2007,7,17]],"date-time":"2007-07-17T00:41:17Z","timestamp":1184632877000},"page":"3452-3454","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":16,"title":["In Vitro Susceptibilities of\n            <i>Mycoplasma putrefaciens<\/i>\n            Field Isolates"],"prefix":"10.1128","volume":"51","author":[{"given":"N. T.","family":"Antunes","sequence":"first","affiliation":[{"name":"Unidad de Epidemiologi\u0301a y Medicina Preventiva, Instituto Universitario de Sanidad Animal (IUSA), Universidad de Las Palmas de Gran Canaria, Arucas, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"Tavi\u0301o","sequence":"additional","affiliation":[{"name":"Microbiologi\u0301a, Departamento de Ciencias Cli\u0301nicas, Facultad de Medicina, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mercier","sequence":"additional","affiliation":[{"name":"Agence Franc\u0327aise de Se\u0301curite\u0301 Sanitaire des Aliments (AFSSA), Laboratoire d'Etudes et de Recherches Caprines, Niort, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. D.","family":"Ayling","sequence":"additional","affiliation":[{"name":"Mycoplasma Group, Statutory and Exotic Bacterial Diseases Department, Veterinary Laboratories Agency (Weybridge), Surrey, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Al-Momani","sequence":"additional","affiliation":[{"name":"Department of Biotechnology and Genetic Engineering, University of Nizwa, Barkat Al Mauz, Nizwa Sultanate of Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Assunc\u0327a\u0303o","sequence":"additional","affiliation":[{"name":"Unidad de Epidemiologi\u0301a y Medicina Preventiva, Instituto Universitario de Sanidad Animal (IUSA), Universidad de Las Palmas de Gran Canaria, Arucas, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. S.","family":"Rosales","sequence":"additional","affiliation":[{"name":"Unidad de Epidemiologi\u0301a y Medicina Preventiva, Instituto Universitario de Sanidad Animal (IUSA), Universidad de Las Palmas de Gran Canaria, Arucas, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. B.","family":"Poveda","sequence":"additional","affiliation":[{"name":"Unidad de Epidemiologi\u0301a y Medicina Preventiva, Instituto Universitario de Sanidad Animal (IUSA), Universidad de Las Palmas de Gran Canaria, Arucas, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"1677","volume":"41","year":"1980","unstructured":"Adler, H. E., A. J. DaMassa, and D. L. Brooks. 1980. Caprine mycoplasmosis: Mycoplasma putrefaciens, a new cause of mastitis in goats. Am. J. Vet. Res.41:1677-1679.","journal-title":"Am. J. Vet. Res."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11250-006-4334-3"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smallrumres.2005.05.019"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2006.08.013"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.20506\/rst.16.3.1062"},{"key":"e_1_3_2_7_2","first-page":"S26","volume":"1","year":"1996","unstructured":"Courvalin, P. 1996. Interpretive reading of in vitro antibiotic susceptibility tests (the antibiogramme). Clin. Microbiol. Infect.1:S26-S34.","journal-title":"Clin. Microbiol. Infect."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/vr.120.17.409"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/45.4.547"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1051\/vetres:2000100"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.7.1267"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800062129"},{"key":"e_1_3_2_13_2","first-page":"130","volume":"5","year":"2001","unstructured":"Mercier, P., D. Lenfant, F. Poumarat, and G. Perrin. 2001. Prevalence of mycoplasma infection within French milking caprine herds, p. 130-133. In J. B. Poveda, A. Fernand\u00e9z, J. Frey, and K. E. Johansson (ed.), Mycoplasmas of ruminants: pathogenicity, diagnostics, epidemiology and molecular genetics,vol 5. European Commission, Brussels, Belgium.","journal-title":"Mycoplasmas of ruminants: pathogenicity, diagnostics, epidemiology and molecular genetics"},{"key":"e_1_3_2_14_2","unstructured":"Terrestrial animal health code 2006"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.10.3142-3150.2002"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.28.1.141"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/vr.135.17.406"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2005.11.290"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.11.4470-4472.2004"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00420-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00420-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T19:23:36Z","timestamp":1645471416000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00420-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["10.1128\/AAC.00420-07"],"URL":"https:\/\/doi.org\/10.1128\/aac.00420-07","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"2007-03-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-07-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}